Search Clinical Trials
Our researchers are currently in need of adult and pediatric study participants to help us pursue better treatments and cures. Participants may receive medical evaluations and procedures, study medication, disease-related education and possible financial compensation for time, travel and participation.
Select a Condition or Specialty
- Allergy
- Alpha-1 Antitrypsin Deficiency
- Asthma
- Cardiology
- Chronic Obstructive Pulmonary Disease (COPD)
- COVID-19 (Coronavirus)
- Cystic Fibrosis
- Eczema (Atopic Dermatitis)
- Environmental & Occupational Health
- Eosinophilic Granulomatosis with Polyangiitis (EGPA)
- Food Allergy
- Gastroenterology
- Idiopathic Pulmonary Fibrosis (IPF)
- Interstitial Lung Disease (Pulmonary Fibrosis)
- Lung Cancer
- Nontuberculous Mycobacteria (NTM)
- Oncology
- Pulmonary Hypertension (PH)
- Respiratory (Pulmonary)
- Rheumatology
- Sarcoidosis
All Clinical Trials
Possible New Treatment for CF and NTM
Researchers in the ABATE Study are testing the safety of a drug called gallium nitrate for people with cystic fibrosis (CF) who also have been diagnosed with nontuberculous mycobacteria (NTM).
- Gender
- Any
- Ages
- 18+
- Compensation
- Provided
- Time Required
- 8 in-person visits, including two 5-day inpatient stays, and 4 phone calls over 28 weeks
Determining How Parenthood Affects Cystic Fibrosis Patients
Surveys have shown that a growing number of cystic fibrosis (CF) patients are considering parenthood, so steps should be taken to better understand the effects of parenthood on CF patients in order to more effectively support them.
- Gender
- Any
- Ages
- 18+
- Compensation
- Provided
- Time Required
- One survey, taking approximately 5 minutes
Assessing a New Investigational Enzyme Replacement Therapy in CF Patients with EPI
Researchers want to know if an investigational oral treatment called ANG003 is safe and to evaluate its effects on nutrient absorption.
- Gender
- Any
- Ages
- 18+
- Compensation
- Provided
- Time Required
- Six in-person visits and two phone calls, occurring within 23-26 days, two in-person visits will require being in the clinic for up to 12 hours
BEACON-CF: Investigational mRNA Therapy for Cystic Fibrosis
For many people living with cystic fibrosis, there are treatments available called cystic fibrosis transmembrane conductance regulator (CFTR) modulators that can help treat the underlying cause of cystic fibrosis. However, more than 5,000 people living with cystic fibrosis have a change in both of their CFTR genes that makes them not expected to benefit from CFTR modulators.
- Gender
- Any
- Ages
- 18-65
- Compensation
- Provided
- Time Required
- 28 weeks with 8 in-person visits and 4 phone calls.
Blood Test to Help Identify Cancer
Researchers want to learn if a blood test can be used to identify cancers in adults. Current or former smokers who have been diagnosed with cancer but haven’t started treatment are needed for this trial. Participants will receive a blood draw and review of their medical history with a research coordinator.
- Gender
- Any
- Ages
- 50+
- Compensation
- Provided
- Time Required
- One in-person visit for enrollment, remote follow up visit 12 months later
Investigational Gene Therapy for Adults with CF
Adults with Cystic Fibrosis who are unable to take CFTR modulators are being asked to participate in a clinical trial for an investigational gene therapy drug known as 4D-710.
- Gender
- Any
- Ages
- 18+
- Compensation
- Provided
- Time Required
- 24 months
.jpg?lang=en-US&ext=.jpg)
Effects of Pregnancy for Cystic Fibrosis Patients
If you are a pregnant with cystic fibrosis, consider participating in this trial to learn how pregnancy affects your health.
- Gender
- Any
- Ages
- 16+
- Compensation
- Provided
- Time Required
- 7 to 9 clinic visits
Adults with Cystic Fibrosis (CF) & Exercise Intolerance
This exercise study is investigating how an already FDA approved drug for treatment of pulmonary vascular disease, sildenafil (Revatio ®), impacts exercise tolerance and capacity in people with cystic fibrosis (CF).
- Gender
- Any
- Ages
- 18+
- Compensation
- Provided
- Time Required
- 16 weeks, five in-person visits, three phone contacts
.jpg?lang=en-US&ext=.jpg)
NICE-CF: Colon Cancer Screening for adults with Cystic Fibrosis
Adults with cystic fibrosis (CF) are at a higher risk of developing colon cancer due to a mutation of the cystic fibrosis transmembrane conductance regulator (CFTR) gene..
- Gender
- Any
- Ages
- 30-75
- Compensation
- Provided
- Time Required
- Three to 12 months, depending on the completion of the at-home test and the colonoscopy
Adult Trials
Assessing a New Investigational Enzyme Replacement Therapy in CF Patients with EPI
Researchers want to know if an investigational oral treatment called ANG003 is safe and to evaluate its effects on nutrient absorption.
- Gender
- Any
- Ages
- 18+
- Compensation
- Provided
- Time Required
- Six in-person visits and two phone calls, occurring within 23-26 days, two in-person visits will require being in the clinic for up to 12 hours
Blood Test to Help Identify Cancer
Researchers want to learn if a blood test can be used to identify cancers in adults. Current or former smokers who have been diagnosed with cancer but haven’t started treatment are needed for this trial. Participants will receive a blood draw and review of their medical history with a research coordinator.
- Gender
- Any
- Ages
- 50+
- Compensation
- Provided
- Time Required
- One in-person visit for enrollment, remote follow up visit 12 months later
Investigational Gene Therapy for Adults with CF
Adults with Cystic Fibrosis who are unable to take CFTR modulators are being asked to participate in a clinical trial for an investigational gene therapy drug known as 4D-710.
- Gender
- Any
- Ages
- 18+
- Compensation
- Provided
- Time Required
- 24 months
Effects of Pregnancy for Cystic Fibrosis Patients
If you are a pregnant with cystic fibrosis, consider participating in this trial to learn how pregnancy affects your health.
- Gender
- Any
- Ages
- 16+
- Compensation
- Provided
- Time Required
- 7 to 9 clinic visits
Adults with Cystic Fibrosis (CF) & Exercise Intolerance
This exercise study is investigating how an already FDA approved drug for treatment of pulmonary vascular disease, sildenafil (Revatio ®), impacts exercise tolerance and capacity in people with cystic fibrosis (CF).
- Gender
- Any
- Ages
- 18+
- Compensation
- Provided
- Time Required
- 16 weeks, five in-person visits, three phone contacts
NICE-CF: Colon Cancer Screening for adults with Cystic Fibrosis
Adults with cystic fibrosis (CF) are at a higher risk of developing colon cancer due to a mutation of the cystic fibrosis transmembrane conductance regulator (CFTR) gene..
- Gender
- Any
- Ages
- 30-75
- Compensation
- Provided
- Time Required
- Three to 12 months, depending on the completion of the at-home test and the colonoscopy